Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurford Capital Regulatory News (BUR)

Share Price Information for Burford Capital (BUR)

Share Price is delayed by 15 minutes
Get Live Data
328.00    -7.40 (-2.21%)
Bid:
326.80
Ask:
328.80
Spread: 2.00 (0.612%)
Market Cap: £718.55m
BUR Live PriceLast checked at - London Stock Exchange

Intraday Burford Capital Share Chart

Rule 8.3- Burren Energy

18 Dec 2007 10:52

Henderson Global Investors Ltd18 December 2007 . FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the City Code on Takeovers and Mergers) 1. KEY INFORMATION Name of person dealing (Note 1) Henderson Global Investors LtdCompany dealt in Burren EnergyClass of relevant security to which the ORD GBP 0.20dealings being disclosed relate (Note 2)Date of dealing 17/12/07 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) Long Short Number (%) Number (%)(1) Relevant securities 119,749 0.0848(2) Derivatives (other than options)(3) Options and agreements to purchase/sellTotal 119,749 0.0848 (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) Class of relevant security: Long Short Number (%) Number (%)(1) Relevant securities(2) Derivatives (other than options)(3) Options and agreements to purchase/sellTotal (c) Rights to subscribe (Note 3) Class of relevant security: Details 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of securities Price per unit (Note 5) Sale 214,173 12.25GBP Sale 22,475 12.29GBP (b) Derivatives transactions (other than options) Product name, e.g. Long/short (Note 6) Number of securities (Note 7) Price per unit (Note 5)CFD CFD Short 1,078,231 12.25GBPCFD Short 332,142 12.29GBP (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product Writing, Number of Exercise Type, e.g. Expiry date Option moneypaid/name,e.g. selling, securities price American, received per unitcall option purchasing, to which the European (Note 5) varying etc. option etc. relates (Note 7) (ii) Exercising Product name, e.g. call option Number of securities Exercise price per unit (Note 5) (d) Other dealings (including new securities) (Note 4) Nature of transaction (Note 8) Details Price per unit (if applicable) (Note 5) 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the persondisclosing and any other person relating to the voting rights of any relevantsecurities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which anyderivative referred to on this form is referenced. If none, this should bestated. .............................................................................. .............................................................................. Is a Supplemental Form 8 attached? (Note 9) NO Date of disclosure 18/12/07Contact name Gavin DoldingTelephone number 020 7818 5217If a connected EFM, name of offeree/offeror with which N/AconnectedIf a connected EFM, state nature of connection (Note 10) N/A Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk SUPPLEMENTAL FORM 8 DETAILS OF OPEN POSITIONS (This form should be attached to Form 8.1, Form 8.1(b)(ii) or Form 8.3, as appropriate) OPEN POSITIONS (Note 1) Product name,e.g. Written or Number of securities Exercise price Type, e.g. Expiry datecall option purchased to which the option (Note 2) American, or derivative relates European etc. Notes 1. Where there are open option positions or open derivative positions (exceptfor CFDs), full details should be given. Full details of any existingagreements to purchase or to sell should also be given on this form. 2. For all prices and other monetary amounts, the currency must be stated. For details of the Code's dealing disclosure requirements, see Rule 8 and itsNotes which can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
29th May 20262:00 pmRNSSterling FX Rate for 2025 Final Dividend
21st May 202612:00 pmRNSNotice of Retail Shareholder Audio Webcast
14th May 202612:00 pmRNSResult of AGM
8th May 202612:00 pmRNS1Q26 Financial Results
5th May 202612:00 pmRNSNotice of 1Q26 Results & Results Call Details
7th Apr 20267:00 amRNSHolding(s) in Company
31st Mar 20267:00 amRNSDirector/PDMR Shareholding & Issue of Equity
30th Mar 20267:00 amRNSBurford Capital Further Statement on YPF
30th Mar 20267:00 amRNSBurford Capital Statement Re YPF Appeal Decision
27th Mar 20263:32 pmRNSBurford Capital Statement re YPF Matter
17th Mar 202612:00 pmRNSCompletion of Share Repurchase Program
9th Mar 20261:45 pmRNSSubstantial Share Purchases by Executive Officers
9th Mar 20261:45 pmRNSSubstantial Share Purchases by Executive Officers
26th Feb 20261:00 pmRNSAnnual Results for Year Ended December 31, 2025
10th Feb 20261:00 pmRNSNotice of 2025 Results & Results Call Details
27th Jan 20261:30 pmRNSPricing of Early Redemption of Bonds Due 2026
15th Jan 20263:41 pmRNSNotice of Early Redemption of Bonds Due 2026
15th Jan 20267:00 amRNSHolding(s) in Company
14th Jan 20267:00 amRNSPricing and Upsizing of Senior Notes Offering
12th Jan 20262:01 pmRNSPrivate Offering of Senior Notes
5th Jan 20261:00 pmRNSIssue of New Shares in Connection with LTIP
23rd Dec 20257:00 amRNSDirector/PDMR Shareholding
23rd Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSDirector/PDMR Shareholding
10th Dec 20257:00 amRNSDirector/PDMR Shareholding
4th Dec 20251:00 pmRNSDirector/PDMR Shareholding
7th Nov 20251:00 pmRNSSterling Conversion Rate for 2025 Interim Dividend
6th Nov 20257:00 amRNSHolding(s) in Company
5th Nov 20251:00 pmRNSAppointment of Joint Corporate Broker
5th Nov 20251:00 pmRNS3Q25 and YTD25 Financial Results
29th Oct 20257:00 amRNSHolding(s) in Company
24th Oct 20257:00 amRNSHolding(s) in Company
23rd Oct 20251:00 pmRNSNotice of 3Q25 Results & Results Call Details
22nd Oct 20251:00 pmRNSYPF Matter Update
10th Oct 20257:00 amRNSHolding(s) in Company
3rd Oct 20257:00 amRNSDirector/PDMR Shareholding & New Share Issuance
1st Oct 20252:00 pmRNSHolding(s) in Company
29th Sep 20251:00 pmRNSInterim Dividend Declaration
29th Sep 20257:00 amRNSHolding(s) in Company
23rd Sep 20259:00 amRNSHolding(s) in Company
26th Aug 20257:00 amRNSDirector/PDMR Shareholding
7th Aug 20251:00 pmRNS2Q25 and YTD25 Financial Results
24th Jul 202512:00 pmRNSNotice of 2Q25 Results & Results Call Details
14th Jul 202512:00 pmRNSClosing of Private Offering of Senior Notes
14th Jul 20257:00 amRNSDirector/PDMR Shareholding
8th Jul 20255:21 pmRNSPricing and Upsizing of Senior Notes Offering
7th Jul 202512:57 pmRNSPrivate Offering of Senior Notes
3rd Jul 202511:00 amRNSIssue of New Shares in Connection With LTIP
2nd Jul 20255:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.